Ascentage Pharma Group International (AAPG) EBITDA (2016 - 2026)
Ascentage Pharma Group International (AAPG) EBITDA from Jun 30, 2016 to Mar 31, 2026. The TTM Ascentage Pharma Group International (AAPG) EBITDA is -$317M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Ascentage Pharma Group International (AAPG) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +61.47% |
| 3 Years TTM | +26.24% |
| 5 Years TTM | +20.03% |
| All Time TTM | +48.20% |
Annual EBITDA change of Ascentage Pharma Group International (AAPG)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$87M | -44.55% |
| 2025 | -$157M | +381.07% |
| 2024 | -$33M | -68.93% |
| 2023 | -$105M | -8.18% |
| 2022 | -$114M | -9.21% |
| 2021 | -$126M | +25.74% |
| 2020 | -$100M | -52.80% |
| 2019 | -$212M | +399.42% |
| 2018 | -$42M | +455.49% |
| 2017 | -$7.63M | -48.57% |
| 2016 | -$15M | N/A |
Comparison Ascentage Pharma Group International (AAPG) five years EBITDA CAGR with competitors
Ascentage Pharma Group International (AAPG) five years EBITDA CAGR is 112.19%.